IInmedical Therapeutics — Seed (estimated) · €800K
Basque medtech Inmedical Therapeutics closed an €800,000 round bringing in casings group Viscofan and the Basque government's Gestión de Capital Riesgo del País Vasco (Grupo SPRI), with Elkargi advising. Funds go to clinical trials for Convergel, a bioadhesive device used in therapeutic endoscopy, ahead of planned 2025 commercialisation.
LeadViscofan
RoundSeed (estimated)
Announced18 Jan 2024
CityVitoria-Gasteiz
SectorHealthtech & Bio · Medtech / Medical devices
Source
W
E
W
E
